Abstract
The purpose of this review is to update knowledge on therapy-related myeloid neoplasms (t-MN), taking into account the new 2008 WHO classification, new genome-wide approaches for the definition of susceptibility towards t-MN and the introduction of new more aggressive treatments in cancer patients.
| Original language | English |
|---|---|
| Pages (from-to) | 672-680 |
| Number of pages | 9 |
| Journal | Current Opinion in Oncology |
| Volume | 23 |
| DOIs | |
| Publication status | Published - 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Humans
- Leukemia, Myeloid, Acute
- Neoplasms, Second Primary
Fingerprint
Dive into the research topics of 'Therapy-related myeloid neoplasms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver